Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
86.6M
Number of holders
113
Total 13F shares, excl. options
50.2M
Shares change
+1.73M
Total reported value, excl. options
$862M
Value change
+$12.3M
Put/Call ratio
1.52
Number of buys
65
Number of sells
-55
Price
$17.17

Significant Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q2 2021

144 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q2 2021.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 50.2M shares of 86.6M outstanding shares and own 58% of the company stock.
Largest 10 shareholders include Avidity Partners Management LP (4.62M shares), BlackRock Inc. (3.52M shares), STATE STREET CORP (3.17M shares), Avoro Capital Advisors LLC (3M shares), Nantahala Capital Management, LLC (2.59M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.49M shares), BVF INC/IL (2.49M shares), BOXER CAPITAL, LLC (2.29M shares), PFM Health Sciences, LP (2.14M shares), and VANGUARD GROUP INC (2.11M shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.